Ozaki, Nobuaki
Goto, Yoshie
Fujii, Norihisa
Oyama, Takuro
Frascello, Karen
Camejo, Ana
Adachi, Tomohide
Article History
Received: 4 October 2024
Accepted: 21 April 2025
First Online: 2 May 2025
<!--Emphasis Type='Bold' removed-->Declarations
:
: NF and TO are employees of Alnylam Japan K.K., KF is an employee of Alnylam Pharmaceuticals Inc., and AC is a former employee of Alnylam Pharmaceuticals Inc. The authors declare no other conflicts of interest.
: The study protocol was approved by the Ethics Committee of Iizuka Hospital, Fukuoka, Japan (approval no. 2020-6, 7th Dec. 2020). Written informed consent was obtained from all patients before inclusion in the study.
: A preprint of this article was uploaded to Research Square ().